Exagen Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Exagen Inc.
- Ownership
- Public
- Status
- Active
- Headquarters country
- United States
- Ticker symbol
- XGN
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001274737
Board of directors
-
Ana Hooker · DirectorSince 2023
-
Brian Birk · DirectorSince 2023
-
Bruce C. Robertson · DirectorSince 2026
-
Chas McKhann · DirectorSince 2026
-
Ebetuel Pallares · DirectorSince 2023
-
Frank Stokes · DirectorSince 2023
-
John Aballi · Director · President and CEOSince 2023
-
Paul Kim · DirectorSince 2023
-
Scott D. Kahn · DirectorSince 2024
-
Tina Susan Nova · DirectorSince 2023
-
Wendy S. Johnson · DirectorSince 2023
Chief executives
John Aballi
· President and CEO
Dates unknown
Board connections
2 of this board's directors also sit on 3 other boards.
- via Tina Susan Nova
- via Tina Susan Nova
- via Chas McKhann
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $0
- 0 purchases by 0 insiders
- Sold, last 12 months
- $628,311
- 5 sales by 2 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 1, 2026 | Black Jeffrey G. Officer (Chief Financial Officer) | Open-market sale | −20,614 | $7.22 | $148,782 |
| Sep 1, 2026 | Black Jeffrey G. Officer (Chief Financial Officer) | Grant or award | +1,571 | $3.02 | $4,740 |
| Mar 12, 2026 | Black Jeffrey G. Officer (Chief Financial Officer) | Grant or award | +75,000 | $3.16 | $237,000 |
| Mar 12, 2026 | John Aballi Director, Officer (President and CEO) | Grant or award | +150,000 | — | — |
| Mar 3, 2026 | John Aballi Director, Officer (President and CEO) | Open-market sale | −15,698 | $3.62 | $56,827 |
| Mar 3, 2026 | John Aballi Director, Officer (President and CEO) | Grant or award | +2,535 | $3.08 | $7,808 |
| Feb 27, 2026 | Black Jeffrey G. Officer (Chief Financial Officer) | Grant or award | +1,511 | $3.08 | $4,654 |
| Feb 24, 2026 | John Aballi Director, Officer (President and CEO) | Open-market sale | −11,430 | $3.61 | $41,262 |
| Feb 24, 2026 | Black Jeffrey G. Officer (Chief Financial Officer) | Open-market sale | −1,584 | $3.61 | $5,718 |
| Oct 16, 2025 | John Aballi Director, Officer (President and CEO) | Open-market sale | −31,787 | $11.82 | $375,722 |
| Sep 2, 2025 | Black Jeffrey G. Officer (Chief Financial Officer) | Open-market sale | −20,466 | $9.79 | $200,362 |
| Mar 25, 2025 | NMSIC Co-Investment Fund, L.P. 10% owner | Open-market sale | −350,000 | $3.30 | $1,155,000 |
| Feb 28, 2025 | John Aballi Director, Officer (President and CEO) | Grant or award | +8,621 | $2.47 | $21,294 |
| Feb 21, 2025 | Black Jeffrey G. Officer (Chief Financial Officer) | Grant or award | +15,000 | — | — |
| Feb 21, 2025 | John Aballi Director, Officer (President and CEO) | Grant or award | +112,500 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.